Progyny Stock Alpha and Beta Analysis

PGNY Stock  USD 15.75  0.31  2.01%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Progyny. It also helps investors analyze the systematic and unsystematic risks associated with investing in Progyny over a specified time horizon. Remember, high Progyny's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Progyny's market risk premium analysis include:
Beta
0.67
Alpha
(0.42)
Risk
5.26
Sharpe Ratio
(0.07)
Expected Return
(0.34)
Please note that although Progyny alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Progyny did 0.42  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Progyny stock's relative risk over its benchmark. Progyny has a beta of 0.67  . As returns on the market increase, Progyny's returns are expected to increase less than the market. However, during the bear market, the loss of holding Progyny is expected to be smaller as well. At this time, Progyny's Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 5.98 in 2024, whereas Price Book Value Ratio is likely to drop 6.06 in 2024.

Enterprise Value

2.15 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Progyny Backtesting, Progyny Valuation, Progyny Correlation, Progyny Hype Analysis, Progyny Volatility, Progyny History and analyze Progyny Performance.
For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.

Progyny Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Progyny market risk premium is the additional return an investor will receive from holding Progyny long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Progyny. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Progyny's performance over market.
α-0.42   β0.67

Progyny expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Progyny's Buy-and-hold return. Our buy-and-hold chart shows how Progyny performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Progyny Market Price Analysis

Market price analysis indicators help investors to evaluate how Progyny stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Progyny shares will generate the highest return on investment. By understating and applying Progyny stock market price indicators, traders can identify Progyny position entry and exit signals to maximize returns.

Progyny Return and Market Media

The median price of Progyny for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 16.46 with a coefficient of variation of 19.12. The daily time series for the period is distributed with a sample standard deviation of 3.42, arithmetic mean of 17.87, and mean deviation of 2.9. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Progyny Inc Stock Price Up 3.71 percent on Sep 20
09/20/2024
2
Disposition of 7977 shares by Peter Anevski of Progyny at 16.76 subject to Rule 16b-3
10/01/2024
3
ModivCare Q3 Earnings and Revenues Lag Estimates
11/06/2024
4
Progyny Inc Q3 2024 Earnings Report Preview What to Look For
11/11/2024
5
Progyny Non-GAAP EPS of 0.40 beats by 0.03, revenue of 286.62M misses by 10.77M
11/12/2024
6
Progyny Inc Q3 2024 Earnings Call Highlights Strong Client Growth Amid Utilization ...
11/13/2024
7
Progyny Third Quarter 2024 Earnings Misses Expectations
11/14/2024
8
Progyny Inc Shares Up 3 percent on Nov 21
11/21/2024

About Progyny Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Progyny or other stocks. Alpha measures the amount that position in Progyny has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding98.1111.3581.169.9
PTB Ratio17.827.626.386.06

Progyny Upcoming Company Events

As portrayed in its financial statements, the presentation of Progyny's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Progyny's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Progyny's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Progyny. Please utilize our Beneish M Score to check the likelihood of Progyny's management manipulating its earnings.
26th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Progyny

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Progyny Stock Analysis

When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.